Vimarsana
Biggest News Aggregation in the World

Submucosal Injection Solution News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Submucosal Injection Solution. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Submucosal Injection Solution Today - Breaking & Trending Today

Olympus to Highlight EVIS X1 Endoscopy System and Colorectal Cancer Screening Solutions at Digestive Disease Week Annual Meeting - Vimarsana News

Olympus to Highlight EVIS X1 Endoscopy System and Colorectal Cancer Screening Solutions at Digestive Disease Week Annual Meeting

/PRNewswire/ -- Olympus, a global medical technology company committed to making people's lives healthier, safer and more fulfilling, announced today that it...

Olympus Launches EndoClot Hemostatic Agents and Submucosal Injection Agent in European Markets - Vimarsana News

Olympus Launches EndoClot Hemostatic Agents and Submucosal Injection Agent in European Markets

/PRNewswire/ -- Olympus today announced the launch of EndoClot® Adhesive (ECA), EndoClot® Polysaccharide Hemostatic Spray (PHS) and EndoClot® Submucosal...

Olympus Europa SE & Co. KG: Olympus Launches EndoClot Hemostatic Agents and Submucosal Injection Agent in European Markets - Vimarsana News

Olympus Europa SE & Co. KG: Olympus Launches EndoClot Hemostatic Agents and Submucosal Injection Agent in European Markets

The EndoClot portfolio supports hemostasis and lifting in endoscopic submucosal dissection or resection during gastrointestinal procedures HAMBURG, Germany, April 20, 2023 /PRNewswire/

Olympus Announces U.S. Distribution of EndoClot Polysaccharide Hemostatic Spray and EndoClot Submucosal Injection Agent - Vimarsana News

Olympus Announces U.S. Distribution of EndoClot Polysaccharide Hemostatic Spray and EndoClot Submucosal Injection Agent

/PRNewswire/ -- Olympus, a leading global medtech company providing innovative solutions for medical and surgical procedures, announced today it will...